Codes of conduct

At Pfizer, integrity means more than just complying with the law. It reflects who we are as a company and as individuals.

 

In addition to our own Code of Conduct, the Blue Book, as an industry, we are subject to regulation by a number of government and industry bodies. They set the standards and processes which ensure that medicines are effective, safe and marketed appropriately.
 

Association of the British Pharmaceutical Industry (ABPI)
The ABPI is the recognised body representing the pharmaceutical industry in the UK. Through its Code of Practice, it sets the standards for the promotion of prescription medicines to health professionals and for information made available to the public about prescription-only medicines. Advertising or promoting prescription-only medicines to the public is prohibited under the ABPI Code and UK law. However, we are allowed to promote medicines to healthcare professionals (HCPs) and other relevant decision makers.
 

The Prescription Medicines Code of Practice Authority (PMCPA)
The PMCPA is a self-regulatory body which was established by the ABPI to independently operate the Code of Practice. It is responsible for investigating any complaints about the activities of pharmaceutical companies.
 

Proprietary Association of Great Britain (PAGB) Code of Practice
The PAGB is the UK trade association which represents the manufacturers of branded over-the-counter medicines, self-care medical devices and food supplements. Through its Code of Practice, it ensures balanced and responsible marketing of self care products, maintaining a fair and positive regulatory environment that encourages product innovation, and promotes the contribution that self-medication can make to people’s health at no cost to the NHS.

 

Gender Pay Gap Report

Responsibility
Gender Pay Gap Report
Gender Pay Gap Report
Gender Pay Gap Report
Gender Pay Gap Report

Gender Pay Gap Report

We're committed to building and maintaining an inclusive working culture to fulfil our purpose: Breakthroughs that change patients’ lives.

PP-PFE-GBR-4020 / October 2021